ArticlePharmacoEconomics2025

The Impact of Tocilizumab Coverage on Health Equity for Inpatients with COVID-19 in the USA: A Distributional Cost-Effectiveness Analysis.

Stacey Kowal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.